Skip to Content

Join the 'Macular Edema' group to help and get support from people like you.

Macular Edema News

Stem Cells Hold Promise, Peril in Treating Seniors' Eye Disease

Posted 15 Mar 2017 by Drugs.com

WEDNESDAY, March 15, 2017 – Stem cells may offer new hope for people losing their vision to age-related macular degeneration, but that promise can come with some peril, new research shows. In one report, three older women were permanently blinded at a Florida eye clinic that performed unproven stem cell treatments on their eyes in 2015, said senior study author Dr. Jeffrey Goldberg. He's chair ...

FDA Approves Genentech’s Lucentis (ranibizumab) Prefilled Syringe

Posted 17 Oct 2016 by Drugs.com

South San Francisco, CA – October 14, 2016 – Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) approved the Lucentis (ranibizumab injection) 0.5 mg prefilled syringe (PFS) as a new method of administering the medicine. Like the Lucentis 0.5 mg vial, the 0.5 mg PFS is approved to treat people with wet age-related ...

Routine Eye Exams See Vision Problems You Miss

Posted 14 Jul 2016 by Drugs.com

WEDNESDAY, July 13, 2016 – Routine eye checkups often pick up unnoticed problems, particularly in older adults, a new study says. "In asymptomatic patients, comprehensive routine optometric eye examinations detect a significant number of new eye conditions and/or results in management changes," said the study's author, Elizabeth Irving, and her colleagues from the University of Waterloo in ...

Experts Undecided on Whether Seniors Should Get Routine Vision Checks

Posted 1 Mar 2016 by Drugs.com

TUESDAY, March 1, 2016 – There's just not enough good data to say whether or not seniors should be routinely screened for vision trouble by their primary care physicians, an influential panel of U.S. experts reports. The U.S. Preventive Services Task Force (USPSTF) believes current data isn't adequate to assess the potential benefits and harms of such screening in people 65 or older. The task ...

Study Compares Drugs for Common Diabetic Eye Disease

Posted 29 Feb 2016 by Drugs.com

MONDAY, Feb. 29, 2016 – People with diabetes are at risk for blurred vision or even a loss of vision from a condition called macular edema. Three drugs for the disease – Avastin, Eylea and Lucentis – vary widely in price, but new research suggests all work equally well for patients with mild vision loss. However, when diabetic macular edema leads to more severe vision loss, researchers found ...

Carrots Do Help Aging Eyes, Study Shows

Posted 8 Oct 2015 by Drugs.com

THURSDAY, Oct. 8, 2015 – Your parents may have told you, "Eat your carrots, they're good for your eyes," and a new study suggests they were on to something. Pigments called carotenoids – which give red or orange hues to carrots, sweet potatoes and orange peppers, or deep greens to produce like spinach, broccoli and kale – may help ward off the age-linked vision ailment known as macular ...

Lucentis Approved for Diabetic Macular Edema

Posted 10 Aug 2012 by Drugs.com

FRIDAY, Aug. 10 – Lucentis (ranibizumab injection) has been approved by the U.S. Food and Drug Administration to treat diabetic macular edema (DME), an eye condition that could threaten a diabetic person's sight, the agency said Friday in a news release. The condition occurs when fluid leaks into the macula, the center of the eye's retina. This leads to macular swelling, causing blurred vision. ...

FDA Approves Lucentis (ranibizumab) for the Treatment of Macular Edema Following Retinal Vein Occlusion

Posted 23 Jun 2010 by Drugs.com

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Jun 23, 2010 - Genentech, Inc., a member of the Roche Group, announced today that the U.S. Food and Drug Administration (FDA) has approved Lucentis (ranibizumab injection) for the treatment of macular edema following retinal vein occlusion (RVO). The FDA approved this new indication after a six-month Priority Review. "This approval provides an ...

Drug-Laser Combination Proves Effective For Diabetic Blindness

Posted 28 Apr 2010 by Drugs.com

Drug-Laser Combination Proves Effective For Diabetic blindness [Los Angeles Times] From Los Angeles Times (CA) (April 28, 2010) Apr. 28--For the first time in a quarter of a century, researchers have identified a new treatment for diabetic macular edema, a potentially blinding disorder that affects about 1 million Americans, researchers said Tuesday. The treatment uses a drug called ranibizumab, ...

Ask a Question

Further Information

Related Condition Support Groups

Diabetic Macular Edema, Eye Conditions

Related Drug Support Groups

fluocinolone, Lucentis, Eylea, Maxidex, Ozurdex, Retisert, Iluvien, ranibizumab, aflibercept, Dexasol, AK-Dex, Decadron Ocumeter, Ocu-Dex